Literature DB >> 19278936

Studies linking smoking-cessation drug with suicide risk spark concerns.

Bridget M Kuehn.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19278936     DOI： 10.1001/jama.2009.293

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

Review 1.  Update in addiction medicine for the generalist.

Authors:  Adam J Gordon; Hillary V Kunins; Darius A Rastegar; Jeanette M Tetrault; Alexander Y Walley
Journal:  J Gen Intern Med       Date:  2010-08-10       Impact factor: 5.128

Review 2.  Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.

Authors:  S Chatterjee; S E Bartlett
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

Review 3.  Varenicline for tobacco dependence: panacea or plight?

Authors:  Jill M Williams; Michael B Steinberg; Marc L Steinberg; Kunal K Gandhi; Rajiv Ulpe; Jonathan Foulds
Journal:  Expert Opin Pharmacother       Date:  2011-06-06       Impact factor: 3.889

4.  Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.

Authors:  Jed E Rose; Frédérique M Behm; Tomas Drgon; Catherine Johnson; George R Uhl
Journal:  Mol Med       Date:  2010-03-17       Impact factor: 6.354

5.  Trends in utilization of smoking cessation agents before and after the passage of FDA boxed warning in the United States.

Authors:  Drishti Shah; Anuj Shah; Xi Tan; Usha Sambamoorthi
Journal:  Drug Alcohol Depend       Date:  2017-05-18       Impact factor: 4.492

6.  Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011.

Authors:  Kyla H Thomas; Richard M Martin; John Potokar; Munir Pirmohamed; David Gunnell
Journal:  BMC Pharmacol Toxicol       Date:  2014-09-30       Impact factor: 2.483

7.  Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Elizabeth Stuller; David Miller; John Giordano; Siobhan Morse; Lee McCormick; William B Downs; Roger L Waite; Debmalya Barh; Dennis Neal; Eric R Braverman; Raquel Lohmann; Joan Borsten; Mary Hauser; David Han; Yijun Liu; Manya Helman; Thomas Simpatico
Journal:  J Addict Res Ther       Date:  2012-11-27

8.  Utilization and effectiveness of pharmacotherapy for tobacco use following admission for exacerbation of COPD.

Authors:  Anne C Melzer; Laura C Feemster; Margaret P Collins; David H Au
Journal:  J Hosp Med       Date:  2015-12-14       Impact factor: 2.960

Review 9.  Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads.

Authors:  Christopher J Armishaw
Journal:  Toxins (Basel)       Date:  2010-06-14       Impact factor: 4.546

10.  Smoking cessation: an economic analysis and review of varenicline.

Authors:  Michele A Faulkner
Journal:  Clinicoecon Outcomes Res       Date:  2009-06-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.